Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure

NCT07561866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16556

Last updated 2026-05-01

No results posted yet for this study

Summary

This observational cohort study evaluates the prognostic impact of diabetes, comorbidity burden, and short-term weight variability among adults with chronic heart failure enrolled in a nationwide remote patient monitoring program in France. Patients were enrolled between September 3 2018 and April 3 2024 as part of routine heart failure care. Baseline demographic, clinical, and treatment data, along with weight measurements collected through telemonitoring, were analyzed. The study aims to assess associations between diabetes status, multimorbidity, and weight variability with survival outcomes using retrospective data from the program database. No study-mandated interventions were performed.

Conditions

Interventions

OTHER

Diabetes Status

Presence or absence of diabetes mellitus recorded at enrolment as part of routine clinical assessment.

OTHER

Comorbidity Burden

Number of chronic comorbid conditions recorded at enrollment, used as a measure of multimorbidity.

OTHER

Weight variability

Short-term variability in body weight calculated from repeated weight measurements collected during routine telemonitoring, used as a marker of dynamic physiological status.

Sponsors & Collaborators

  • Satelia

    lead INDUSTRY

Principal Investigators

  • Paul Valensi · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2024-04-03
Completion
2024-04-03

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561866 on ClinicalTrials.gov